½ÃÀ庸°í¼­
»óǰÄÚµå
1576561

¼¼°èÀÇ ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå : Àӽдܰè, µð¹ÙÀ̽º À¯Çü, Àڱݿø, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Fetus-voice Meter Market by Pregnancy Stage (Second Trimester, Third Trimester), Device Type (Handheld, Tabletop), Funding Source, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀº 2023³â¿¡ 10¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 10¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.67%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 14¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÅÂ¾Æ À½¼º ¹ÌÅʹ žư¡ ³»´Â ¹Ì¹¦ÇÑ ¼Ò¸®¸¦ ÁõÆø ¹× ºÐ¼®ÇØ, žÆÀÇ °Ç°­ »óųª ¹ßÀ°ÀÇ ÁøÇà »óȲÀ» ÆÄ¾ÇÇϱâ À§Çؼ­ ¼³°èµÈ Ư¼öÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ¹ÌÅÍÀÇ Çʿ伺Àº žÆÀÇ °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇϰí, ÀÌ»óÀ» È®ÀÎÇϰí, ÀӽŠÁß ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ °Ç°­ °ü¸® Àü¹®°¡¸¦ µ½´Â Áß¿äÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× ¿ëµµ´Â º´¿ø, Ŭ¸®´Ð, ¿ø°Ý ÀÇ·á Ç÷§Æû µî Ãâ»ê Àü Ä¡·á ¼³Á¤¿¡ À̸£±â ¶§¹®¿¡ ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§°¡ ³Ð½À´Ï´Ù. ÷´Ü Ãâ»ý Àü Áø´Ü ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ¸ðü¿Í žÆÀÇ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â °ÍÀÌÀÌ ½ÃÀåÀÇ ¸Å¿ì Áß¿äÇÑ ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, žÆÀÇ °Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í Ãâ»ê Àü Äɾî ÀåºñÀÇ ±â¼úÀû Áøº¸°¡ ÇÔ²² ½ÃÀå È®´ëÀÇ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ½ÅÈï ½ÃÀå, ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«´Â ÇコÄɾî ÀÎÇÁ¶ó °³¼±°ú ÇコÄɾî ÁöÃâ Áõ°¡·Î °­·ÂÇÑ ¼ºÀå °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ³ôÀº ºñ¿ë, ±ÔÁ¦ ¹®Á¦, Ç¥ÁØÈ­ ºÎÁ· µîÀÇ Á¦¾àÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾÷°è´Â ¶ÇÇÑ ÀåºñÀÇ Á¤È®¼º È®º¸, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¿ì·Á ´ëÀÀ, ƯÁ¤ Áö¿ªÀÇ ¹®È­Àû À庮 ±Øº¹ µîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇÑ Çõ½Å ºÐ¾ß·Î´Â AI ¹× IoT ±â¼ú°úÀÇ ÅëÇÕÀ» ÅëÇÑ ÅÂ¾Æ À½¼º ¹ÌÅÍÀÇ Á¤È®¼º°ú È޴뼺 Çâ»ó, º¸´Ù Æø³ÐÀº Á¢±Ù¼ºÀ» À§ÇÑ ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç °³¹ß, »ç¿ë ÆíÀǼº Ãß±¸ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽ºÀÇ Ãß°¡ °³¼± µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸±â°ü ¹× ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Çù¾÷Àº Á¦Ç° °³¹ßÀÇ È¹±âÀûÀÎ °³¼±°ú ½ÃÀå ħÅõ °³¼±À¸·Î À̾îÁý´Ï´Ù. ½ÃÀå °æÀïÀº ²÷ÀÓ¾ø´Â ±â¼úÀÇ ¹ßÀü°ú ±ÔÁ¦ ¿ªÇп¡ ´Þ·Á ÀÖ½À´Ï´Ù. µû¶ó¼­ ±â¾÷Àº ÀûÀÀ·ÂÀ» À¯ÁöÇϸ鼭 °í°´ ÁöÇâÀ» °üöÇÏ°í ÆÄÆ®³Ê½Ê°ú Àü·«Àû Á¦ÈÞ ±âȸ¸¦ ÆÄ¾ÇÇÏ¿© ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ ³ô¿© ³ª°¥ Çʿ䰡 ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 10¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 10¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 14¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 4.67%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Ãâ»ý Àü Äɾî¿Í žÆÀÇ °Ç°­ Áß½ÃÀÇ °íÁ¶
    • ÀӽŠÇÕº´Áõ Áõ°¡
    • ÀçÅà °Ç°­ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °í±Þ ÅÂ¾Æ ¸ð´ÏÅ͸µ ÀåºñÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç°úÀÇ ÅëÇÕ
    • AI ¹× ¸Ó½Å·¯´× ±â´É °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ °üÇÑ ¹®Á¦

Porter's Five Forces: ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Force Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Ãâ»ý Àü Äɾî¿Í žÆÀÇ °Ç°­¿¡ ÁßÁ¡ÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
      • ÀӽŠÇÕº´ÁõÀÇ ÀÌȯÀ² »ó½Â
      • ÀçÅà °Ç°­ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • °í±Þ ÅÂ¾Æ ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ³ôÀº ºñ¿ë
    • ±âȸ
      • ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç°úÀÇ ÅëÇÕ
      • AI¿Í ¸Ó½Å·¯´× ±â´É °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • °úÁ¦
      • µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ °üÇÑ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : °æ·®À̱⠶§¹®¿¡ ¿þ¾î·¯ºí ÅÂ¾Æ À½¼º°è ¼ö¿ä°¡ Áõ°¡
    • ÀÀ¿ë : ÅÂ¾Æ À½¼º°èÀÇ °íÀ§Çè ÀӽЏð´ÏÅ͸µ¿¡ÀÇ È°¿ë È®´ë
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå : ÀӽŠ´Ü°èº°

  • ÀӽŠÁß±â
  • ÀӽŠÈıâ

Á¦7Àå ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå : µð¹ÙÀ̽º À¯Çüº°

  • ÇÚµåÇïµå
  • Ź»ó

Á¦8Àå ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå : Àڱݿøº°

  • °³ÀÎ
  • °ø°ø

Á¦9Àå ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÅÂ¾Æ À½¼º ¹ÌÅÍ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • BloomlifeÀÇ ¸ðü ¹× ÅÂ¾Æ ¸ð´ÏÅ͸µ ÀåÄ¡°¡ FDA ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù.
    • Philips´Â Á¶±â ¹ß°ß°ú Áú ³ôÀº Ãâ»ý Àü Äɾ ´ëÇÑ ¼¼°èÀÇ Á¢±ÙÀ» Çâ»ó½ÃŰ´Â ÃÖ÷´Ü »êºÎÀΰú¿ë ÃÊÀ½ÆÄ ±â¼úÀ» ¹ßÇ¥
  • Àü·« ºÐ¼®°ú Á¦¾È
JHS 24.11.01

The Fetus-voice Meter Market was valued at USD 1.03 billion in 2023, expected to reach USD 1.07 billion in 2024, and is projected to grow at a CAGR of 4.67%, to USD 1.41 billion by 2030.

A fetus-voice meter is a specialized medical device designed to amplify and analyze the subtle sounds produced by unborn infants, offering insights into fetal well-being and developmental progress. The necessity for this meter lies in its potential to provide critical data that can aid healthcare professionals in monitoring fetal health, identifying anomalies, and reducing the risk of complications during pregnancy. Its application spans prenatal care settings, including hospitals, clinics, and telemedicine platforms, thus presenting a wide end-use scope. The increasing adoption of advanced prenatal diagnostic technologies and a rising focus on maternal and fetal health are pivotal growth factors in this market. Additionally, heightened awareness about fetal health, coupled with technological advancement in prenatal care equipment, offers lucrative opportunities for market expansion. Emerging markets, particularly in Asia-Pacific and Latin America, exhibit robust growth potential due to improving healthcare infrastructure and increasing healthcare expenditure. Nonetheless, limitations such as high costs, regulatory challenges, and a lack of standardization can impede market growth. The industry also faces challenges such as ensuring device accuracy, addressing data privacy concerns, and overcoming cultural barriers in certain regions. To foster business growth, innovation areas include enhancing the accuracy and portability of fetus-voice meters through integration with AI and IoT technologies, developing cost-effective solutions for broader accessibility, and further improving user interfaces for ease of use. Collaboration with research institutions and healthcare providers can lead to breakthroughs in product development and improved market penetration. The nature of the market is competitive, driven by continuous technological advancements and regulatory dynamics. It requires companies to remain adaptable and customer-focused, seizing opportunities for partnerships and strategic alliances to enhance their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 1.03 billion
Estimated Year [2024] USD 1.07 billion
Forecast Year [2030] USD 1.41 billion
CAGR (%) 4.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fetus-voice Meter Market

The Fetus-voice Meter Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing emphasis on prenatal care and the health of unborn babies
    • Rising prevalence of pregnancy complications
    • Growing consumer demand for home-based healthcare solutions
  • Market Restraints
    • High cost of advanced fetal monitoring devices
  • Market Opportunities
    • Integration with telemedicine and remote monitoring solutions
    • Rising investment for development of AI and machine learning capabilities
  • Market Challenges
    • Issues regarding data privacy and security concerns

Porter's Five Forces: A Strategic Tool for Navigating the Fetus-voice Meter Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fetus-voice Meter Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fetus-voice Meter Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fetus-voice Meter Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fetus-voice Meter Market

A detailed market share analysis in the Fetus-voice Meter Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fetus-voice Meter Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fetus-voice Meter Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fetus-voice Meter Market

A strategic analysis of the Fetus-voice Meter Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fetus-voice Meter Market, highlighting leading vendors and their innovative profiles. These include Advanced Instrumentations Inc., Analogic Corporation, Bionet Co., Ltd., BPL Medical Technologies Pvt. Ltd., Cardinal Health, Inc., CHISON Medical Technologies Co., Ltd., CooperSurgical Inc., Datrend Systems Inc., Edan Instruments, Inc., GE HealthCare Technologies, Inc., Huntleigh Healthcare Limited, India Medtronic Private Limited, Lutech Industries, Inc., Neoventa Medical AB, Philips Healthcare Inc., Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Spacelabs Healthcare, Sunray Medical Apparatus Co., Ltd., Toitu Co., Ltd., Trivitron Healthcare Pvt. Ltd., and Vyaire Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Fetus-voice Meter Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Pregnancy Stage, market is studied across Second Trimester and Third Trimester.
  • Based on Device Type, market is studied across Handheld and Tabletop.
  • Based on Funding Source, market is studied across Private and Public.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing emphasis on prenatal care and the health of unborn babies
      • 5.1.1.2. Rising prevalence of pregnancy complications
      • 5.1.1.3. Growing consumer demand for home-based healthcare solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced fetal monitoring devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration with telemedicine and remote monitoring solutions
      • 5.1.3.2. Rising investment for development of AI and machine learning capabilities
    • 5.1.4. Challenges
      • 5.1.4.1. Issues regarding data privacy and security concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Increasing demand for wearable fetus-voice meters due to its lightweight nature
    • 5.2.2. Application: Expanding utilization of fetus-voice meters for high-risk pregnancy monitoring
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fetus-voice Meter Market, by Pregnancy Stage

  • 6.1. Introduction
  • 6.2. Second Trimester
  • 6.3. Third Trimester

7. Fetus-voice Meter Market, by Device Type

  • 7.1. Introduction
  • 7.2. Handheld
  • 7.3. Tabletop

8. Fetus-voice Meter Market, by Funding Source

  • 8.1. Introduction
  • 8.2. Private
  • 8.3. Public

9. Fetus-voice Meter Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics
  • 9.4. Homecare Settings
  • 9.5. Hospitals

10. Americas Fetus-voice Meter Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Fetus-voice Meter Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Fetus-voice Meter Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bloomlife's maternal and fetal monitoring device receives FDA approval.
    • 13.3.2. Philips unveils cutting-edge OB/GYN ultrasound technology to improve early detection and global access to quality prenatal care
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Instrumentations Inc.
  • 2. Analogic Corporation
  • 3. Bionet Co., Ltd.
  • 4. BPL Medical Technologies Pvt. Ltd.
  • 5. Cardinal Health, Inc.
  • 6. CHISON Medical Technologies Co., Ltd.
  • 7. CooperSurgical Inc.
  • 8. Datrend Systems Inc.
  • 9. Edan Instruments, Inc.
  • 10. GE HealthCare Technologies, Inc.
  • 11. Huntleigh Healthcare Limited
  • 12. India Medtronic Private Limited
  • 13. Lutech Industries, Inc.
  • 14. Neoventa Medical AB
  • 15. Philips Healthcare Inc.
  • 16. Samsung Medison Co., Ltd.
  • 17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18. Siemens Healthineers AG
  • 19. Spacelabs Healthcare
  • 20. Sunray Medical Apparatus Co., Ltd.
  • 21. Toitu Co., Ltd.
  • 22. Trivitron Healthcare Pvt. Ltd.
  • 23. Vyaire Medical Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦